Streetbeat News

Products Services

TAK

VGK

Takeda has received European Commission approval for FRUZAQLA (fruquintinib) for the treatment of metastatic colorectal cancer in adults previously treated with standard therapies. This approval follows a positive CHMP opinion and previous FDA approval, and is based on results from the Phase 3 FRESCO-2 trial. FRUZAQLA is the first novel targeted therapy in the EU for mCRC regardless of biomarker status in over a decade.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2024 | 8:01 pm

AAPL

IWM

JPM

MSFT

NVDA

XHB

XLF

XLK

A leading market strategist suggests that the market could take a routine pause after record highs, with key events like the rebalancing of the Technology Select Sector SPDR Fund (XLK) and the reconstitution of the Russell 2000 coming up. Nvidia (NVDA) recently surpassed Apple (AAPL) and Microsoft (MSFT) in market value, but investors might look to book profits. Financials and homebuilder stocks are highlighted as potential opportunities.

Portfolio Pulse from Chris Katje

June 21, 2024 | 7:57 pm

RMD

ResMed shares are trading lower following sleep apnea data from Lilly.

Portfolio Pulse from Bill Haddad

June 21, 2024 | 7:54 pm

LLY

Eli Lilly announced positive results from its SURMOUNT-OSA Phase 3 trials evaluating tirzepatide for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. The drug achieved all primary and key secondary endpoints, including up to a 62.8% reduction in the apnea-hypopnea index. Lilly has submitted tirzepatide for FDA approval and will initiate submissions to other global regulatory agencies.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2024 | 7:51 pm

GME

GameStop (NYSE:GME) shares have dropped 5% amid significant volatility. The company held its annual shareholder meeting, where CEO Ryan Cohen outlined a strategic pivot towards profitability through cost reductions and a streamlined retail presence. Discussions also emerged about adopting a Bitcoin standard. Additionally, GameStop filed a prospectus supplement for its at-the-market offering program, allowing the sale of up to 75 million shares. Insider trading activity was noted with the general counsel selling shares.

Portfolio Pulse from Vaishali Prayag

June 21, 2024 | 7:43 pm

AAWH

CBSTF

HITI

TSNDF

VRNOF

The New York Cannabis Control Board approved home cultivation rules, allowing adults to grow weed at home. New cannabis retail locations are opening in New York, Maryland, Florida, Ohio, Illinois, Virginia, and beyond US borders. Companies like TerrAscend, Verano Holdings, Klutch Cannabis, The Cannabist Company, Ascend Wellness, and High Tide are expanding their retail footprints.

Portfolio Pulse from Jelena Martinovic

June 21, 2024 | 7:32 pm

DELL

MSTR

Michael Dell, CEO of Dell Technologies, has shown interest in Bitcoin through social media interactions with Michael Saylor, CEO of MicroStrategy. This has led to speculation that Dell Technologies might invest in Bitcoin, similar to MicroStrategy's strategy.

Portfolio Pulse from Khyathi Dalal

June 21, 2024 | 7:30 pm

GNENF

PILBF

Pilbara Minerals (OTC:PILBF) plans to invest $800 million to expand its Pilgangoora lithium operation in Australia, aiming to significantly increase production capacity. The expansion aligns with the growing demand for electric vehicle batteries. Pilbara is also exploring a partnership with Ganfeng Lithium (OTCPK:GNENF) for a lithium conversion facility.

Portfolio Pulse from Stjepan Kalinic

June 21, 2024 | 7:25 pm

BMMJ

Body and Mind Inc. (OTCQB:BMMJ) reported its Q3 2024 financial results, showing a 30% YoY reduction in net loss. The company is focusing on streamlining operations and developing valuable assets. Key highlights include growth in its Illinois dispensary and receiving a New Jersey Annual license for a new dispensary. Financials show a slight increase in revenue and gross profit, with a notable reduction in net loss.

Portfolio Pulse from Jelena Martinovic

June 21, 2024 | 7:08 pm

MCD

QSR

WEN

McDonald's Corp. (NYSE:MCD) shares rose 2.41% after announcing a new $5 meal deal to attract price-conscious customers amid rising fast-food prices. This initiative aims to compete with similar value meals from Burger King (NYSE:QSR) and Wendy's (NASDAQ:WEN).

Portfolio Pulse from Vaishali Prayag

June 21, 2024 | 7:03 pm